DIPHENHYDRAMINE HCL, IBUPROFEN

DIPHENHYDRAMINE HCL, IBUPROFEN was reported 4445 times

DIPHENHYDRAMINE HCL, IBUPROFEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMPAIRED ABILITY TO USE MACHINERY 1 0.0500
1 PHARYNGEAL NEOPLASM BENIGN 1 0.0357
2 BLOOD ALCOHOL ABNORMAL 1 0.0303
3 DRUG EFFECT PROLONGED 15 0.0272
4 PRODUCT DIFFICULT TO SWALLOW 27 0.0266
5 FOREIGN BODY IN RESPIRATORY TRACT 23 0.0175
6 INCREASED VISCOSITY OF NASAL SECRETION 1 0.0167
7 ENEMA ADMINISTRATION 1 0.0152
8 PRODUCT SHAPE ISSUE 13 0.0138
9 INTERVENTIONAL PROCEDURE 1 0.0135
10 HANGOVER 40 0.0114
11 FOREIGN BODY 44 0.0110
12 CRANIAL NERVE INJURY 1 0.0103
13 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 283 0.0097
14 PHARYNGEAL INJURY 2 0.0095
15 PRODUCT COMMINGLING 10 0.0094
16 NAIL BED TENDERNESS 1 0.0088
17 DRUG EFFECT DELAYED 32 0.0071
18 LUDWIG ANGINA 1 0.0069
19 CAPSULE PHYSICAL ISSUE 1 0.0069
20 PRODUCT SIZE ISSUE 35 0.0065
21 POOR QUALITY DRUG ADMINISTERED 40 0.0062
22 HEPATOJUGULAR REFLUX 1 0.0060
23 DRUG EFFECT FASTER THAN EXPECTED 2 0.0060
24 DRUG SCREEN FALSE POSITIVE 15 0.0054
25 GLOMERULONEPHRITIS CHRONIC 1 0.0053
26 ADENOIDECTOMY 2 0.0052
27 EYELID SENSORY DISORDER 1 0.0051
28 ENERGY INCREASED 29 0.0049
29 WRONG DRUG ADMINISTERED 43 0.0048
30 GLOBAL AMNESIA 1 0.0047
31 RAPID EYE MOVEMENTS SLEEP ABNORMAL 2 0.0047
32 JAW CLICKING 1 0.0047
33 FEELING OF RELAXATION 3 0.0044
34 ACUTE HIV INFECTION 1 0.0040
35 DRUG LABEL CONFUSION 1 0.0040
36 FALSE POSITIVE INVESTIGATION RESULT 4 0.0040
37 DRUG TOLERANCE INCREASED 3 0.0038
38 MARITAL PROBLEM 2 0.0037
39 PRODUCT SELECTION ERROR 4 0.0036
40 CIRCADIAN RHYTHM SLEEP DISORDER 3 0.0036
41 OCULAR SURFACE DISEASE 1 0.0036
42 PRE-EXISTING CONDITION IMPROVED 22 0.0035
43 RESTLESS LEGS SYNDROME 59 0.0032
44 VIOLENCE-RELATED SYMPTOM 5 0.0032
45 MUSCLE TONE DISORDER 1 0.0032
46 DUPLICATE THERAPY ERROR 1 0.0031
47 HYPERVIGILANCE 3 0.0031
48 ANISOCYTOSIS 2 0.0030
49 SLEEP TALKING 5 0.0029
50 GENITAL SWELLING 2 0.0029
51 CONTRAINDICATED DRUG ADMINISTERED 2 0.0029
52 FOREIGN BODY IN THROAT 9 0.0029
53 DRUG EFFECT INCOMPLETE 99 0.0027
54 AMPHETAMINES POSITIVE 2 0.0027
55 MICTURITION FREQUENCY DECREASED 2 0.0027
56 FEELING JITTERY 49 0.0026
57 JOINT HYPEREXTENSION 1 0.0026
58 BLOOD ALCOHOL INCREASED 2 0.0026
59 PHYSICAL PRODUCT LABEL ISSUE 3 0.0025
60 POOR QUALITY SLEEP 54 0.0025
61 DRUG WITHDRAWAL HEADACHE 1 0.0024
62 MIDDLE INSOMNIA 45 0.0024
63 DEPERSONALISATION 2 0.0024
64 PRODUCT USED FOR UNKNOWN INDICATION 3 0.0024
65 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
66 LAZINESS 4 0.0023
67 THERAPEUTIC PRODUCT EFFECT VARIABLE 9 0.0023
68 MOUTH BREATHING 1 0.0023
69 GINGIVAL BLISTER 1 0.0023
70 DRUG SCREEN POSITIVE 18 0.0023
71 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0022
72 PRODUCT LABEL ISSUE 15 0.0022
73 PNEUMOPERITONEUM 4 0.0022
74 SCROTAL SWELLING 2 0.0021
75 SOMNOLENCE 424 0.0021
76 OPIATES POSITIVE 1 0.0021
77 RESTLESSNESS 75 0.0020
78 PRODUCT CLOSURE REMOVAL DIFFICULT 2 0.0020
79 KELOID SCAR 1 0.0019
80 URETEROLITHIASIS 2 0.0019
81 EXPULSION OF MEDICATION 1 0.0019
82 PSYCHOMOTOR HYPERACTIVITY 31 0.0019
83 PRODUCT NAME CONFUSION 2 0.0018
84 PRODUCT PHYSICAL ISSUE 37 0.0018
85 EXPIRED DRUG ADMINISTERED 9 0.0018
86 ENCEPHALOMALACIA 1 0.0018
87 DYSPRAXIA 1 0.0018
88 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
89 CHOKING 34 0.0017
90 FLASHBACK 1 0.0017
91 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
92 AURICULAR SWELLING 1 0.0017
93 INTENTIONAL PRODUCT MISUSE 145 0.0017
94 PRODUCT USE COMPLAINT 26 0.0016
95 CHOKING SENSATION 9 0.0016
96 FEELING DRUNK 12 0.0016
97 GASTRIC NEOPLASM 1 0.0016
98 CHALAZION 1 0.0016
99 DRUG EFFECT DECREASED 84 0.0016
100 NIGHTMARE 53 0.0015
101 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
102 ORAL MUCOSAL DISCOLOURATION 1 0.0015
103 TONGUE DRY 2 0.0015
104 IMPAIRED SELF-CARE 3 0.0014
105 FOREARM FRACTURE 1 0.0014
106 ECHOCARDIOGRAM ABNORMAL 2 0.0014
107 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
108 DRUG EFFECT LESS THAN EXPECTED 21 0.0014
109 ALCOHOL INTOLERANCE 1 0.0014
110 PRODUCT USE IN UNAPPROVED INDICATION 346 0.0014
111 DRUG TOLERANCE 7 0.0014
112 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
113 BRAIN STEM SYNDROME 1 0.0013
114 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
115 ABNORMAL DREAMS 36 0.0013
116 EXPIRED PRODUCT ADMINISTERED 42 0.0013
117 HERPES ZOSTER DISSEMINATED 1 0.0012
118 WRONG DOSE 3 0.0012
119 CARTILAGE ATROPHY 1 0.0012
120 IIIRD NERVE PARALYSIS 1 0.0012
121 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
122 ACNE PUSTULAR 1 0.0012
123 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
124 TROPONIN I INCREASED 2 0.0012
125 PRODUCT TASTE ABNORMAL 16 0.0012
126 APTYALISM 1 0.0012
127 CORONARY ARTERY DISSECTION 1 0.0012
128 GINGIVAL ERYTHEMA 1 0.0012
129 OESOPHAGEAL OBSTRUCTION 1 0.0012
130 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
131 ROTATOR CUFF REPAIR 2 0.0011
132 NON-SMALL CELL LUNG CANCER METASTATIC 1 0.0011
133 CEREBELLAR ATROPHY 1 0.0011
134 TERMINAL INSOMNIA 2 0.0011
135 COELIAC DISEASE 11 0.0011
136 OPHTHALMIC HERPES ZOSTER 2 0.0011
137 LIP BLISTER 3 0.0011
138 LIGAMENT DISORDER 1 0.0011
139 NONSPECIFIC REACTION 6 0.0011
140 PHARYNGEAL HYPOAESTHESIA 1 0.0011
141 SOMNAMBULISM 7 0.0011
142 CEREBELLAR ATAXIA 1 0.0010
143 GASTRIC HAEMORRHAGE 12 0.0010
144 INFUSION SITE NODULE 1 0.0010
145 BLADDER CATHETERISATION 1 0.0010
146 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 7 0.0010
147 PRODUCT LABEL CONFUSION 6 0.0010
148 ALCOHOL INTERACTION 2 0.0010
149 ANIMAL SCRATCH 1 0.0010
150 OESOPHAGEAL PAIN 4 0.0010
151 FORMICATION 7 0.0010
152 THERAPEUTIC RESPONSE UNEXPECTED 43 0.0010
153 PHYSICAL ASSAULT 2 0.0010
154 CARPAL TUNNEL DECOMPRESSION 1 0.0009
155 SCREAMING 6 0.0009
156 CHEILITIS 5 0.0009
157 REACTION TO DRUG EXCIPIENTS 2 0.0009
158 FEELING ABNORMAL 220 0.0009
159 CLAUSTROPHOBIA 1 0.0009
160 DYSPHAGIA 87 0.0009
161 ACARODERMATITIS 1 0.0009
162 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
163 ASTHENOPIA 5 0.0009
164 PRODUCT FORMULATION ISSUE 6 0.0009
165 INSOMNIA 240 0.0009
166 TONGUE BLISTERING 2 0.0009
167 DRUG INEFFECTIVE 1176 0.0009
168 DRUG EFFECT VARIABLE 1 0.0009
169 INITIAL INSOMNIA 9 0.0009
170 EYELID DISORDER 2 0.0009
171 REACTION TO EXCIPIENT 2 0.0009
172 APHTHOUS STOMATITIS 2 0.0009
173 NERVOUSNESS 45 0.0009
174 UTERINE DISORDER 2 0.0009
175 ALLODYNIA 1 0.0009
176 PRURITUS GENITAL 2 0.0008
177 HEAD DISCOMFORT 15 0.0008
178 PRODUCT PACKAGING ISSUE 8 0.0008
179 HYPERSOMNIA 24 0.0008
180 APPARENT DEATH 3 0.0008
181 PRODUCT PACKAGING CONFUSION 2 0.0008
182 SNORING 3 0.0008
183 ORAL DISCOMFORT 11 0.0008
184 PRODUCT COMPLAINT 20 0.0008
185 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
186 ADNEXA UTERI PAIN 1 0.0008
187 EUPHORIC MOOD 8 0.0008
188 EPIGASTRIC DISCOMFORT 3 0.0008
189 NON-HODGKIN'S LYMPHOMA 1 0.0008
190 PROSTATOMEGALY 3 0.0008
191 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
192 THROAT IRRITATION 34 0.0008
193 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
194 BODY MASS INDEX INCREASED 1 0.0007
195 HEART RATE ABNORMAL 4 0.0007
196 JOINT INSTABILITY 1 0.0007
197 SLEEP TERROR 3 0.0007
198 APPENDIX DISORDER 1 0.0007
199 FEAR 19 0.0007
200 RETCHING 15 0.0007
201 VITAMIN B12 DECREASED 2 0.0007
202 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
203 ESCHERICHIA SEPSIS 2 0.0007
204 SLUGGISHNESS 7 0.0007
205 IMPETIGO 1 0.0007
206 ODYNOPHAGIA 4 0.0007
207 MYELOFIBROSIS 2 0.0007
208 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47 0.0007
209 EAR DISORDER 3 0.0007
210 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
211 SEDATION 17 0.0006
212 ORAL MUCOSAL ERYTHEMA 1 0.0006
213 ROSACEA 3 0.0006
214 THERAPEUTIC RESPONSE CHANGED 4 0.0006
215 CYSTITIS INTERSTITIAL 1 0.0006
216 ACUTE LEUKAEMIA 1 0.0006
217 OROPHARYNGEAL BLISTERING 1 0.0006
218 OEDEMA MOUTH 2 0.0006
219 MUSCLE TWITCHING 14 0.0006
220 INTENTIONAL PRODUCT USE ISSUE 53 0.0006
221 ILLUSION 1 0.0006
222 ACCIDENTAL OVERDOSE 22 0.0006
223 HYPOAESTHESIA ORAL 9 0.0006
224 WRONG PRODUCT ADMINISTERED 4 0.0006
225 FOOD AVERSION 1 0.0006
226 EXPOSURE TO SARS-COV-2 1 0.0006
227 BLADDER NEOPLASM 1 0.0006
228 REGURGITATION 2 0.0006
229 TACHYPHRENIA 2 0.0006
230 MALABSORPTION 3 0.0006
231 INTENTIONAL DRUG MISUSE 12 0.0006
232 BREAST DISCHARGE 1 0.0006
233 RENAL PAIN 6 0.0006
234 FEAR OF DISEASE 1 0.0006
235 PRODUCT CONTAMINATION 2 0.0006
236 PARAPARESIS 1 0.0006
237 APPLICATION SITE DISCOMFORT 1 0.0006
238 DRY MOUTH 45 0.0006
239 ESSENTIAL HYPERTENSION 1 0.0005
240 PARADOXICAL DRUG REACTION 2 0.0005
241 METAMORPHOPSIA 1 0.0005
242 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
243 GRANULOCYTE COUNT DECREASED 1 0.0005
244 LYMPH NODE PAIN 1 0.0005
245 AURA 1 0.0005
246 OVERDOSE 115 0.0005
247 NARCOLEPSY 1 0.0005
248 LIP DISORDER 1 0.0005
249 PHARYNGEAL OEDEMA 8 0.0005
250 MOTION SICKNESS 1 0.0005
251 SENSATION OF HEAVINESS 2 0.0005
252 ATROPHY 1 0.0005
253 EARLY SATIETY 1 0.0005
254 URINE ODOUR ABNORMAL 3 0.0005
255 SLEEP DISORDER 36 0.0005
256 SINUS HEADACHE 3 0.0005
257 GINGIVAL PAIN 4 0.0005
258 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
259 TINNITUS 23 0.0005
260 CARDIAC DISCOMFORT 1 0.0005
261 LIPIDS INCREASED 1 0.0005
262 GASTRIC DISORDER 17 0.0005
263 HOMICIDAL IDEATION 2 0.0005
264 DRY THROAT 5 0.0005
265 NASAL DRYNESS 3 0.0005
266 AGITATION 35 0.0005
267 MUSCLE FATIGUE 2 0.0005
268 TONGUE DISCOMFORT 2 0.0005
269 BODY HEIGHT DECREASED 5 0.0005
270 ALCOHOLISM 2 0.0005
271 DEREALISATION 1 0.0005
272 ABSCESS INTESTINAL 1 0.0005
273 FAECES DISCOLOURED 10 0.0005
274 TONGUE DISCOLOURATION 2 0.0005
275 BACTERIAL TEST POSITIVE 1 0.0004
276 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
277 FEAR OF DEATH 1 0.0004
278 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
279 IMPAIRED DRIVING ABILITY 5 0.0004
280 HAEMOGLOBIN INCREASED 2 0.0004
281 SCAB 5 0.0004
282 NIGHT SWEATS 14 0.0004
283 FLANK PAIN 4 0.0004
284 SKIN ABRASION 2 0.0004
285 FAECAL INCONTINENCE 2 0.0004
286 SWELLING FACE 27 0.0004
287 ABDOMINAL DISCOMFORT 69 0.0004
288 BREATH ODOUR 1 0.0004
289 HORMONE LEVEL ABNORMAL 2 0.0004
290 BRONCHITIS CHRONIC 1 0.0004
291 INCORRECT DOSAGE ADMINISTERED 2 0.0004
292 EYE OEDEMA 1 0.0004
293 DENTAL OPERATION 1 0.0004
294 INTENTIONAL OVERDOSE 26 0.0004
295 PENIS DISORDER 1 0.0004
296 INFREQUENT BOWEL MOVEMENTS 1 0.0004
297 HEART RATE IRREGULAR 9 0.0004
298 LABYRINTHITIS 1 0.0004
299 EYE DISORDER 13 0.0004
300 EXTRA DOSE ADMINISTERED 16 0.0004
301 PARKINSON'S DISEASE 1 0.0004
302 PRODUCT COLOUR ISSUE 2 0.0004
303 STOMACH DISCOMFORT 2 0.0004
304 DELUSION 6 0.0004
305 HIATUS HERNIA 5 0.0004
306 PRODUCT ODOUR ABNORMAL 4 0.0004
307 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
308 ANORECTAL DISCOMFORT 2 0.0004
309 BLOOD POTASSIUM ABNORMAL 1 0.0004
310 BLISTER 21 0.0004
311 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
312 PRURITUS GENERALISED 8 0.0004
313 POST PROCEDURAL INFECTION 3 0.0004
314 CLUMSINESS 1 0.0004
315 POLYURIA 3 0.0004
316 CLONUS 1 0.0004
317 ORAL FUNGAL INFECTION 1 0.0004
318 TOOTH FRACTURE 4 0.0004
319 PROSTATIC DISORDER 2 0.0004
320 PRODUCT USE ISSUE 68 0.0004
321 VERTIGO 22 0.0004
322 LIP SWELLING 12 0.0004
323 DRUG TOLERANCE DECREASED 1 0.0004
324 DIZZINESS 177 0.0004
325 EJACULATION DISORDER 1 0.0004
326 OESOPHAGEAL STENOSIS 1 0.0004
327 HYPERTONIA 2 0.0003
328 LIP PAIN 1 0.0003
329 FIBULA FRACTURE 1 0.0003
330 MUSCLE STRAIN 3 0.0003
331 INCORRECT DOSE ADMINISTERED 79 0.0003
332 BILIARY COLIC 1 0.0003
333 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
334 GRIP STRENGTH DECREASED 3 0.0003
335 COLD SWEAT 6 0.0003
336 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
337 CREPITATIONS 1 0.0003
338 POLLAKIURIA 14 0.0003
339 TOOTHACHE 6 0.0003
340 LOSS OF EMPLOYMENT 1 0.0003
341 PRESYNCOPE 8 0.0003
342 MASTICATION DISORDER 1 0.0003
343 DYSAESTHESIA 1 0.0003
344 ANGER 11 0.0003
345 DYSPEPSIA 32 0.0003
346 DIASTOLIC DYSFUNCTION 1 0.0003
347 DYSGEUSIA 24 0.0003
348 PERSONALITY CHANGE 3 0.0003
349 THINKING ABNORMAL 6 0.0003
350 INFUSION SITE EXTRAVASATION 2 0.0003
351 DYSKINESIA 13 0.0003
352 LACERATION 3 0.0003
353 INFUSION SITE SWELLING 2 0.0003
354 DRUG EFFECT INCREASED 1 0.0003
355 PHOTOPSIA 2 0.0003
356 NON-CARDIAC CHEST PAIN 1 0.0003
357 ABDOMINAL PAIN UPPER 65 0.0003
358 BLADDER PAIN 1 0.0003
359 ORAL PAIN 7 0.0003
360 DISCOMFORT 19 0.0003
361 PROCTALGIA 2 0.0003
362 MULTIPLE DRUG OVERDOSE INTENTIONAL 1 0.0003
363 LOOSE TOOTH 1 0.0003
364 PALPITATIONS 36 0.0003
365 TREMOR 51 0.0003
366 HALLUCINATION 23 0.0003
367 VITREOUS FLOATERS 3 0.0003
368 PSYCHOTIC DISORDER 9 0.0003
369 INJECTION SITE INFECTION 1 0.0003
370 LISTLESS 1 0.0003
371 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
372 LYME DISEASE 1 0.0003
373 POST-TRAUMATIC STRESS DISORDER 2 0.0003
374 PRODUCT ADMINISTRATION ERROR 6 0.0003
375 THROAT TIGHTNESS 8 0.0003
376 EYE SWELLING 11 0.0003
377 DIABETIC RETINOPATHY 1 0.0003
378 LIMB DISCOMFORT 9 0.0003
379 LEFT VENTRICULAR FAILURE 1 0.0003
380 PARANOIA 5 0.0003
381 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
382 MICTURITION DISORDER 1 0.0003
383 FEELING COLD 8 0.0003
384 HUNGER 4 0.0003
385 HYPERREFLEXIA 1 0.0003
386 RASH MACULAR 10 0.0003
387 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
388 PAPULE 2 0.0003
389 LOGORRHOEA 1 0.0003
390 IRRITABILITY 17 0.0003
391 THIRST 5 0.0003
392 DEVICE PLACEMENT ISSUE 1 0.0003
393 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
394 FRUSTRATION 1 0.0003
395 DECREASED ACTIVITY 3 0.0003
396 FACIAL BONES FRACTURE 1 0.0003
397 DISORIENTATION 11 0.0003
398 PARAESTHESIA ORAL 4 0.0003
399 PANIC REACTION 2 0.0003
400 AMNESIA 18 0.0003
401 CAROTID ARTERY OCCLUSION 1 0.0003
402 HYPOAESTHESIA 41 0.0003
403 MOUTH HAEMORRHAGE 2 0.0003
404 HEART RATE INCREASED 27 0.0003
405 PSYCHIATRIC SYMPTOM 2 0.0003
406 DIPLOPIA 7 0.0003
407 BONE DENSITY ABNORMAL 1 0.0003
408 GASTRITIS 7 0.0003
409 LOSS OF CONTROL OF LEGS 1 0.0003
410 FACE INJURY 1 0.0003
411 GASTRIC ULCER 5 0.0003
412 MICTURITION URGENCY 3 0.0003
413 GINGIVAL DISORDER 1 0.0003
414 OESOPHAGEAL DISORDER 1 0.0003
415 CONCUSSION 2 0.0003
416 NICOTINE DEPENDENCE 2 0.0003
417 FAECES HARD 1 0.0003
418 SWOLLEN TONGUE 8 0.0003
419 SPLENOMEGALY 3 0.0003
420 KIDNEY INFECTION 5 0.0003
421 HAEMATOCHEZIA 14 0.0003
422 HALLUCINATION, AUDITORY 4 0.0003
423 ULCER 4 0.0003
424 UPPER LIMB FRACTURE 5 0.0003
425 CEREBRAL ATROPHY 1 0.0003
426 OBSTRUCTION 1 0.0003
427 BLOOD DISORDER 2 0.0002
428 OROPHARYNGEAL PAIN 23 0.0002
429 MUSCLE DISORDER 2 0.0002
430 MALAISE 108 0.0002
431 APPLICATION SITE DISCOLOURATION 1 0.0002
432 BACK DISORDER 4 0.0002
433 GOITRE 1 0.0002
434 DEMYELINATION 1 0.0002
435 BALANCE DISORDER 21 0.0002
436 APPLICATION SITE EXFOLIATION 1 0.0002
437 PHOTOSENSITIVITY REACTION 4 0.0002
438 GASTROINTESTINAL PERFORATION 1 0.0002
439 ACCIDENTAL EXPOSURE 1 0.0002
440 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
441 HALLUCINATION, VISUAL 5 0.0002
442 HEPATIC PAIN 1 0.0002
443 VITAMIN D DECREASED 2 0.0002
444 FATIGUE 182 0.0002
445 MUSCULOSKELETAL DISCOMFORT 4 0.0002
446 HORDEOLUM 1 0.0002
447 HYSTERECTOMY 2 0.0002
448 SUICIDE ATTEMPT 14 0.0002
449 SKIN SWELLING 2 0.0002
450 CHAPPED LIPS 1 0.0002
451 CONDITION AGGRAVATED 70 0.0002
452 LOCAL SWELLING 4 0.0002
453 IMMOBILE 1 0.0002
454 HAEMORRHAGIC ANAEMIA 1 0.0002
455 ABNORMAL BEHAVIOUR 9 0.0002
456 GINGIVAL SWELLING 1 0.0002
457 BLOOD CREATINE INCREASED 1 0.0002
458 EYE HAEMORRHAGE 3 0.0002
459 GLOSSODYNIA 5 0.0002
460 HAEMARTHROSIS 2 0.0002
461 SNEEZING 5 0.0002
462 OPTIC NEURITIS 2 0.0002
463 INJECTION SITE PAPULE 1 0.0002
464 MEMORY IMPAIRMENT 30 0.0002
465 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
466 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
467 DRUG INTOLERANCE 21 0.0002
468 DYSURIA 8 0.0002
469 EYE OPERATION 1 0.0002
470 NERVE COMPRESSION 2 0.0002
471 DIVERTICULITIS 6 0.0002
472 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
473 PROCEDURAL PAIN 6 0.0002
474 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
475 INTERCEPTED MEDICATION ERROR 1 0.0002
476 HAEMOPTYSIS 6 0.0002
477 SQUAMOUS CELL CARCINOMA 2 0.0002
478 FEELING HOT 13 0.0002
479 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15 0.0002
480 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
481 BLOOD URINE PRESENT 4 0.0002
482 VIRAL INFECTION 7 0.0002
483 SPEECH DISORDER 11 0.0002
484 SKIN DISORDER 7 0.0002
485 MEDICATION RESIDUE PRESENT 1 0.0002
486 URTICARIA 35 0.0002
487 APHAGIA 1 0.0002
488 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
489 HYPOKINESIA 3 0.0002
490 FINGER DEFORMITY 1 0.0002
491 APATHY 3 0.0002
492 DYSSTASIA 6 0.0002
493 DRUG DEPENDENCE 33 0.0002
494 HYPERSENSITIVITY 38 0.0002
495 HEPATOMEGALY 2 0.0002
496 APPLICATION SITE BURN 1 0.0002
497 BREATH SOUNDS ABNORMAL 1 0.0002
498 FOOT OPERATION 1 0.0002
499 DRUG INTERACTION 32 0.0002
500 ABDOMINAL TENDERNESS 1 0.0002
501 ANEURYSM 1 0.0002
502 AGEUSIA 5 0.0002
503 BURNING SENSATION 14 0.0002
504 BRAIN INJURY 2 0.0002
505 PRODUCT QUALITY ISSUE 27 0.0002
506 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
507 HAEMATEMESIS 5 0.0002
508 DRUG LEVEL DECREASED 2 0.0002
509 BLOOD PRESSURE INCREASED 30 0.0002
510 NEPHROLITHIASIS 9 0.0002
511 PETIT MAL EPILEPSY 1 0.0002
512 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
513 INCREASED UPPER AIRWAY SECRETION 1 0.0002
514 CEREBRAL ISCHAEMIA 1 0.0002
515 FLATULENCE 11 0.0002
516 ANKLE FRACTURE 3 0.0002
517 TENDONITIS 3 0.0002
518 CRYING 7 0.0002
519 DEAFNESS 5 0.0002
520 WEIGHT FLUCTUATION 2 0.0002
521 ANXIETY 54 0.0002
522 SCRATCH 2 0.0002
523 RASH ERYTHEMATOUS 9 0.0002
524 EATING DISORDER 4 0.0002
525 MOVEMENT DISORDER 6 0.0002
526 FOOD POISONING 1 0.0002
527 DYSARTHRIA 7 0.0002
528 MUSCLE SPASMS 34 0.0002
529 MUSCLE TIGHTNESS 3 0.0002
530 HEADACHE 116 0.0002
531 BLOOD POTASSIUM INCREASED 3 0.0002
532 MENSTRUATION DELAYED 2 0.0002
533 OESOPHAGITIS 2 0.0002
534 FAECALOMA 1 0.0002
535 MANIA 3 0.0002
536 DRUG LEVEL INCREASED 3 0.0002
537 DENTAL CARIES 2 0.0002
538 FOOT DEFORMITY 2 0.0002
539 NERVE INJURY 2 0.0002
540 DEMENTIA 5 0.0002
541 EYE PRURITUS 6 0.0002
542 ANGIOPATHY 1 0.0002
543 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
544 PERONEAL NERVE PALSY 1 0.0002
545 GENERALISED ERYTHEMA 1 0.0002
546 CHOLECYSTECTOMY 2 0.0002
547 LETHARGY 10 0.0002
548 METABOLIC DISORDER 1 0.0002
549 RENAL DISORDER 8 0.0002
550 PARAESTHESIA 27 0.0002
551 HYPERCHLORHYDRIA 1 0.0002
552 PAIN IN EXTREMITY 50 0.0002
553 ATAXIA 2 0.0002
554 ACCIDENT 2 0.0002
555 GAIT DISTURBANCE 32 0.0002
556 DISTURBANCE IN ATTENTION 9 0.0002
557 WRIST FRACTURE 2 0.0002
558 RASH PRURITIC 9 0.0002
559 LACRIMATION INCREASED 5 0.0002
560 INJECTION SITE VESICLES 1 0.0002
561 MENTAL IMPAIRMENT 4 0.0002
562 NOCTURIA 2 0.0002
563 PANIC ATTACK 6 0.0002
564 NEURALGIA 4 0.0002
565 LOSS OF CONSCIOUSNESS 21 0.0002
566 DRUG ADMINISTRATION ERROR 5 0.0002
567 ENCEPHALOPATHY 4 0.0002
568 MUSCLE SPASTICITY 2 0.0002
569 DRUG ABUSER 1 0.0002
570 EMOTIONAL DISORDER 5 0.0002
571 ARTHROPATHY 9 0.0002
572 OLIGURIA 1 0.0002
573 VISION BLURRED 22 0.0002
574 PHOTOPHOBIA 3 0.0002
575 BLEPHAROSPASM 1 0.0002
576 FRACTURE 3 0.0002
577 CONSTIPATION 34 0.0002
578 OEDEMA PERIPHERAL 19 0.0002
579 GENITAL HAEMORRHAGE 2 0.0002
580 CARDIAC FLUTTER 1 0.0002
581 INCOHERENT 1 0.0002
582 ORAL HERPES 3 0.0002
583 BRADYPHRENIA 1 0.0002
584 SINUS DISORDER 3 0.0002
585 DEPRESSED MOOD 8 0.0002
586 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
587 GAIT INABILITY 5 0.0001
588 CHOLECYSTITIS CHRONIC 1 0.0001
589 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
590 FULL BLOOD COUNT DECREASED 3 0.0001
591 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
592 SINUS CONGESTION 2 0.0001
593 FEEDING DISORDER 3 0.0001
594 TASTE DISORDER 3 0.0001
595 OCULAR HYPERAEMIA 7 0.0001
596 EPISTAXIS 11 0.0001
597 EYE MOVEMENT DISORDER 1 0.0001
598 HAEMATURIA 5 0.0001
599 ERYTHEMA 30 0.0001
600 ECCHYMOSIS 1 0.0001
601 CORONARY ARTERY OCCLUSION 2 0.0001
602 INFLUENZA LIKE ILLNESS 12 0.0001
603 PERIPHERAL COLDNESS 2 0.0001
604 APPLICATION SITE RASH 2 0.0001
605 JOINT EFFUSION 1 0.0001
606 LYMPHOEDEMA 1 0.0001
607 ENCEPHALITIS 1 0.0001
608 COORDINATION ABNORMAL 2 0.0001
609 PERIPHERAL SWELLING 22 0.0001
610 DEFAECATION URGENCY 1 0.0001
611 VOMITING 67 0.0001
612 MOUTH ULCERATION 3 0.0001
613 CONFUSIONAL STATE 23 0.0001
614 HAND FRACTURE 1 0.0001
615 JOINT INJURY 3 0.0001
616 HYPERHIDROSIS 18 0.0001
617 SUBDURAL HAEMATOMA 2 0.0001
618 DERMATITIS BULLOUS 1 0.0001
619 BACK PAIN 32 0.0001
620 FLUSHING 14 0.0001
621 INTENTIONAL UNDERDOSE 1 0.0001
622 ORAL DISORDER 1 0.0001
623 MELAENA 3 0.0001
624 APPLICATION SITE PAIN 3 0.0001
625 NASAL CONGESTION 8 0.0001
626 BLINDNESS TRANSIENT 1 0.0001
627 PRURITUS 52 0.0001
628 URINARY INCONTINENCE 4 0.0001
629 SKIN HAEMORRHAGE 2 0.0001
630 ARTHROPOD BITE 1 0.0001
631 STEVENS-JOHNSON SYNDROME 3 0.0001
632 RASH PAPULAR 3 0.0001
633 HOT FLUSH 10 0.0001
634 PAROSMIA 1 0.0001
635 MUSCULAR WEAKNESS 15 0.0001
636 COUGH 37 0.0001
637 AORTIC ANEURYSM 1 0.0001
638 BOWEL MOVEMENT IRREGULARITY 1 0.0001
639 NAUSEA 103 0.0001
640 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
641 VISUAL IMPAIRMENT 16 0.0001
642 COGNITIVE DISORDER 6 0.0001
643 MULTIPLE ALLERGIES 1 0.0001
644 PRODUCT PRESCRIBING ERROR 3 0.0001
645 MEDICATION ERROR 7 0.0001
646 RESPIRATORY TRACT CONGESTION 2 0.0001
647 CYSTITIS 4 0.0001
648 ATRIAL FLUTTER 1 0.0001
649 ASTHENIA 47 0.0001
650 SENSORY DISTURBANCE 2 0.0001
651 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
652 EYE PAIN 7 0.0001
653 FRUSTRATION TOLERANCE DECREASED 1 0.0001
654 HAIR DISORDER 1 0.0001
655 MENSTRUAL DISORDER 1 0.0001
656 ACUTE CORONARY SYNDROME 1 0.0001
657 AGGRESSION 6 0.0001
658 DYSPHONIA 7 0.0001
659 ROAD TRAFFIC ACCIDENT 5 0.0001
660 WITHDRAWAL SYNDROME 5 0.0001
661 UNEVALUABLE EVENT 9 0.0001
662 DRUG USE DISORDER 1 0.0001
663 PAIN 73 0.0001
664 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
665 OSTEOARTHRITIS 5 0.0001
666 CIRCULATORY COLLAPSE 2 0.0001
667 URINARY TRACT INFECTION 20 0.0001
668 FALL 39 0.0001
669 BLOOD GLUCOSE INCREASED 22 0.0001
670 RECTAL HAEMORRHAGE 5 0.0001
671 RASH GENERALISED 3 0.0001
672 STOMATITIS 7 0.0001
673 MIGRAINE 11 0.0001
674 RESPIRATORY TRACT INFECTION 3 0.0001
675 ABDOMINAL DISTENSION 12 0.0001
676 DIARRHOEA 74 0.0001
677 MUSCULOSKELETAL PAIN 6 0.0001
678 APPLICATION SITE ERYTHEMA 3 0.0001
679 BLOOD CALCIUM INCREASED 1 0.0001
680 HEART RATE DECREASED 4 0.0001
681 HYPERTENSION 24 0.0001
682 LUNG INFILTRATION 1 0.0001
683 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
684 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
685 CARDIOTOXICITY 1 0.0001
686 FACIAL PAIN 1 0.0001
687 PAIN OF SKIN 3 0.0001
688 ANAL INCONTINENCE 1 0.0001
689 CHILLS 13 0.0001
690 OROPHARYNGEAL DISCOMFORT 1 0.0001
691 LIP DRY 1 0.0001
692 MOOD ALTERED 3 0.0001
693 SYNCOPE 11 0.0001
694 DEPRESSION 25 0.0001
695 DEPENDENCE 6 0.0001
696 SUICIDAL IDEATION 10 0.0001
697 BRAIN NEOPLASM 1 0.0001
698 WEIGHT INCREASED 24 0.0001
699 DEFORMITY 1 0.0001
700 ARTERIOSCLEROSIS 1 0.0001
701 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
702 NEUROPATHY PERIPHERAL 10 0.0001
703 DISEASE RECURRENCE 5 0.0001
704 CONVULSION 6 0.0001
705 SLEEP APNOEA SYNDROME 2 0.0001
706 ANGINA PECTORIS 3 0.0001
707 INCREASED APPETITE 2 0.0001
708 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
709 PRESCRIBED OVERDOSE 2 0.0001
710 DIZZINESS POSTURAL 1 0.0001
711 EAR PAIN 2 0.0001
712 AUTOIMMUNE DISORDER 1 0.0001
713 BONE PAIN 6 0.0001
714 ARTHRITIS 8 0.0001
715 LIGAMENT SPRAIN 1 0.0001
716 BLADDER DISORDER 1 0.0001
717 DYSPNOEA 57 0.0001
718 BLOOD PRESSURE ABNORMAL 2 0.0001
719 RESPIRATORY DISORDER 3 0.0001
720 EMPHYSEMA 1 0.0001
721 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
722 MOTOR DYSFUNCTION 1 0.0001
723 BODY TEMPERATURE INCREASED 2 0.0001
724 CHEST DISCOMFORT 10 0.0001
725 EAR DISCOMFORT 1 0.0001
726 CHEST PAIN 18 0.0001
727 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
728 CARDIAC DISORDER 9 0.0001
729 PETECHIAE 1 0.0001
730 HEAD INJURY 3 0.0001
731 ABDOMINAL PAIN 22 0.0001
732 FULL BLOOD COUNT ABNORMAL 1 0.0001
733 MOOD SWINGS 3 0.0001
734 MYALGIA 16 0.0001
735 IMPAIRED WORK ABILITY 2 0.0001
736 HIP FRACTURE 3 0.0001
737 IRRITABLE BOWEL SYNDROME 2 0.0001
738 LIVER FUNCTION TEST INCREASED 2 0.0001
739 HYPOACUSIS 4 0.0001
740 RHINORRHOEA 6 0.0001
741 BACK INJURY 1 0.0001
742 PRODUCT DISPENSING ERROR 2 0.0001
743 MUSCULOSKELETAL STIFFNESS 8 0.0001
744 DRUG WITHDRAWAL SYNDROME 8 0.0001
745 TOOTH DISORDER 2 0.0001
746 URINARY RETENTION 3 0.0001
747 WEIGHT DECREASED 25 0.0001
748 NECK PAIN 5 0.0001
749 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
750 BLOOD CALCIUM DECREASED 1 0.0001
751 DERMATITIS CONTACT 1 0.0001
752 RASH 38 0.0001
753 SHOCK 2 0.0001
754 WHEEZING 5 0.0001
755 CHOLECYSTITIS 1 0.0001
756 MYOCLONUS 1 0.0001
757 HYPERLIPIDAEMIA 1 0.0001
758 MUSCLE RIGIDITY 1 0.0001
759 BLOOD PRESSURE FLUCTUATION 2 0.0001
760 BLOOD GLUCOSE DECREASED 4 0.0001
761 LOCALISED INFECTION 2 0.0001
762 DEHYDRATION 11 0.0001
763 BURSITIS 1 0.0001
764 ADRENAL INSUFFICIENCY 1 0.0001
765 FIBROMYALGIA 2 0.0001
766 CYTOPENIA 1 0.0001
767 INJECTION SITE EXTRAVASATION 1 0.0001
768 ABASIA 2 0.0001
769 GENERALISED OEDEMA 1 0.0001
770 ILEUS 1 0.0001
771 HAIR COLOUR CHANGES 1 0.0001
772 DRY EYE 4 0.0001
773 DYSPNOEA EXERTIONAL 3 0.0001
774 INTESTINAL OBSTRUCTION 3 0.0001
775 COLITIS 3 0.0001
776 ABDOMINAL PAIN LOWER 2 0.0001
777 FLUID RETENTION 4 0.0001
778 INTRAOCULAR PRESSURE INCREASED 1 0.0001
779 HYPOPHAGIA 2 0.0001
780 INFUSION SITE PAIN 1 0.0001
781 ANAPHYLACTIC SHOCK 2 0.0001
782 INFLAMMATION 4 0.0001
783 DECREASED APPETITE 18 0.0001
784 INJECTION SITE INDURATION 1 0.0001
785 NODULE 1 0.0001
786 INCORRECT PRODUCT STORAGE 1 0.0001
787 BEDRIDDEN 1 0.0001
788 NASOPHARYNGITIS 14 0.0001
789 ORAL CANDIDIASIS 1 0.0001
790 ANKYLOSING SPONDYLITIS 1 0.0001
791 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
792 ADVERSE REACTION 1 0.0001
793 INJECTION SITE BRUISING 6 0.0001
794 EAR INFECTION 2 0.0001
795 HAIR TEXTURE ABNORMAL 1 0.0001
796 MENSTRUATION IRREGULAR 2 0.0001
797 MALIGNANT MELANOMA 1 0.0001
798 ARTHRALGIA 31 0.0001
799 BLINDNESS 3 0.0001
800 IMPAIRED GASTRIC EMPTYING 1 0.0001
801 GINGIVAL BLEEDING 1 0.0001
802 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
803 CONTUSION 7 0.0001
804 RESPIRATORY DISTRESS 2 0.0001
805 ATRIAL FIBRILLATION 7 0.0001
806 INFLUENZA 8 0.0001
807 APHONIA 1 0.0001
808 BLOOD TEST ABNORMAL 1 0.0001
809 LYMPHOPENIA 1 0.0001
810 MOBILITY DECREASED 5 0.0001
811 EYE IRRITATION 4 0.0001
812 PRODUCT SUBSTITUTION ISSUE 4 0.0001
813 ANOSMIA 1 0.0001
814 INJECTION SITE HAEMATOMA 1 0.0001
815 GASTROENTERITIS 1 0.0001
816 CARDIOMYOPATHY 1 0.0001
817 CATARACT 4 0.0001
818 HAEMORRHAGE 7 0.0001
819 HAEMORRHAGE INTRACRANIAL 1 0.0001
820 BLOOD POTASSIUM DECREASED 2 0.0001
821 JOINT SWELLING 8 0.0001
822 CORONARY ARTERY DISEASE 2 0.0001
823 DRUG DISPENSING ERROR 1 0.0001
824 INSURANCE ISSUE 1 0.0001
825 HIP ARTHROPLASTY 1 0.0001
826 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
827 MUSCULOSKELETAL CHEST PAIN 1 0.0001
828 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
829 LUNG INFECTION 1 0.0001
830 BLOOD CHOLESTEROL INCREASED 3 0.0001
831 SWELLING 6 0.0001
832 BASAL CELL CARCINOMA 1 0.0001
833 NERVOUS SYSTEM DISORDER 2 0.0001
834 PULMONARY EMBOLISM 6 0.0001
835 COMA 3 0.0001
836 MULTIPLE SCLEROSIS 3 0.0001
837 INFECTION 9 0.0001
838 LUNG DISORDER 3 0.0001
839 IMPAIRED HEALING 2 0.0001
840 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
841 VISUAL ACUITY REDUCED 2 0.0001
842 BLOOD PRESSURE DECREASED 4 0.0001
843 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
844 TYPE 2 DIABETES MELLITUS 2 0.0001
845 SINUSITIS 6 0.0001
846 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
847 ANAEMIA 11 0.0001
848 METASTASES TO LIVER 1 0.0001
849 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
850 INJECTION SITE ERYTHEMA 7 0.0001
851 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
852 ISCHAEMIC STROKE 1 0.0001
853 ALOPECIA 11 0.0001
854 GASTROINTESTINAL DISORDER 5 0.0001
855 GOUT 1 0.0001
856 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
857 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
858 GASTROENTERITIS VIRAL 1 0.0001
859 COMPLICATION OF DEVICE REMOVAL 1 0.0001
860 PELVIC PAIN 1 0.0001
861 HYPERGLYCAEMIA 2 0.0001
862 UNDERDOSE 4 0.0001
863 INJECTION SITE MASS 2 0.0001
864 SEPSIS 6 0.0001
865 PSORIASIS 7 0.0001
866 BLOOD SODIUM DECREASED 1 0.0001
867 MUSCULOSKELETAL DISORDER 1 0.0001
868 HERPES ZOSTER 3 0.0001
869 GLAUCOMA 1 0.0001
870 ERUCTATION 1 0.0001
871 DYSTONIA 1 0.0001
872 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
873 HAEMORRHOIDS 1 0.0001
874 DISABILITY 1 0.0001
875 INJECTION SITE HAEMORRHAGE 4 0.0001
876 PLEURAL EFFUSION 3 0.0000
877 DRUG ABUSE 4 0.0000
878 DERMATITIS 1 0.0000
879 KNEE ARTHROPLASTY 1 0.0000
880 CEREBROVASCULAR ACCIDENT 8 0.0000
881 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
882 VAGINAL HAEMORRHAGE 2 0.0000
883 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
884 PRODUCT STORAGE ERROR 4 0.0000
885 OFF LABEL USE 40 0.0000
886 LIVER DISORDER 2 0.0000
887 DEVICE ISSUE 4 0.0000
888 ADVERSE DRUG REACTION 4 0.0000
889 THERAPY NON-RESPONDER 2 0.0000
890 SKIN DISCOLOURATION 2 0.0000
891 INJURY 3 0.0000
892 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
893 DIABETIC KETOACIDOSIS 1 0.0000
894 LIVER INJURY 1 0.0000
895 BRONCHITIS 3 0.0000
896 CELLULITIS 2 0.0000
897 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
898 ACNE 3 0.0000
899 GASTRIC CANCER 1 0.0000
900 THERAPY CESSATION 2 0.0000
901 ERECTILE DYSFUNCTION 1 0.0000
902 DRUG RESISTANCE 1 0.0000
903 ILLNESS 4 0.0000
904 HAEMATOMA 1 0.0000
905 EXPOSURE VIA SKIN CONTACT 1 0.0000
906 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
907 MUCOSAL INFLAMMATION 1 0.0000
908 PLATELET COUNT DECREASED 4 0.0000
909 JAUNDICE 1 0.0000
910 PNEUMONIA 12 0.0000
911 FREQUENT BOWEL MOVEMENTS 1 0.0000
912 OEDEMA 2 0.0000
913 LIMB INJURY 1 0.0000
914 TREATMENT NONCOMPLIANCE 2 0.0000
915 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
916 CARDIAC ARREST 3 0.0000
917 DRUG DOSE OMISSION 6 0.0000
918 INJECTION SITE PAIN 11 0.0000
919 PANCYTOPENIA 2 0.0000
920 RENAL IMPAIRMENT 3 0.0000
921 OXYGEN SATURATION DECREASED 2 0.0000
922 SKIN EXFOLIATION 3 0.0000
923 PAIN IN JAW 1 0.0000
924 INTENTIONAL DOSE OMISSION 1 0.0000
925 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
926 HYPOTENSION 7 0.0000
927 SEIZURE 4 0.0000
928 MYOCARDIAL INFARCTION 6 0.0000
929 COVID-19 6 0.0000
930 LABORATORY TEST ABNORMAL 1 0.0000
931 TACHYCARDIA 3 0.0000
932 HEPATIC FAILURE 1 0.0000
933 APHASIA 1 0.0000
934 EMOTIONAL DISTRESS 4 0.0000
935 EXPOSURE DURING PREGNANCY 2 0.0000
936 DEEP VEIN THROMBOSIS 2 0.0000
937 PRODUCT DOSE OMISSION 2 0.0000
938 BLOOD CREATININE INCREASED 2 0.0000
939 CHOLELITHIASIS 1 0.0000
940 FUNGAL INFECTION 1 0.0000
941 NEOPLASM MALIGNANT 2 0.0000
942 HEPATIC ENZYME INCREASED 2 0.0000
943 INJECTION SITE REACTION 2 0.0000
944 PYREXIA 10 0.0000
945 DELIRIUM 1 0.0000
946 THERAPY INTERRUPTED 2 0.0000
947 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
948 SKIN BURNING SENSATION 2 0.0000
949 NO ADVERSE EVENT 5 0.0000
950 THROMBOCYTOPENIA 3 0.0000
951 CHRONIC KIDNEY DISEASE 2 0.0000
952 DIABETES MELLITUS 2 0.0000
953 INJECTION SITE SWELLING 2 0.0000
954 ABORTION SPONTANEOUS 1 0.0000
955 THROMBOSIS 2 0.0000
956 NEUTROPHIL COUNT DECREASED 1 0.0000
957 DEVICE DISLOCATION 1 0.0000
958 MENTAL DISORDER 1 0.0000
959 ANGIOEDEMA 1 0.0000
960 DRY SKIN 3 0.0000
961 ADVERSE EVENT 2 0.0000
962 HYPOKALAEMIA 1 0.0000
963 ARRHYTHMIA 1 0.0000
964 PRODUCT DOSE OMISSION ISSUE 6 0.0000
965 LEUKOPENIA 1 0.0000
966 ACUTE KIDNEY INJURY 3 0.0000
967 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
968 HOSPITALISATION 3 0.0000
969 HAEMOGLOBIN DECREASED 2 0.0000
970 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
971 ECZEMA 1 0.0000
972 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
973 ANAPHYLACTIC REACTION 1 0.0000
974 TOXICITY TO VARIOUS AGENTS 3 0.0000
975 ASTHMA 2 0.0000
976 DEATH 15 0.0000
977 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
978 ILL-DEFINED DISORDER 1 0.0000
979 INFUSION RELATED REACTION 1 0.0000
980 RENAL FAILURE 2 0.0000
981 NEUTROPENIA 2 0.0000
982 DEVICE MALFUNCTION 1 0.0000
983 CARDIAC FAILURE CONGESTIVE 1 0.0000
984 DISEASE PROGRESSION 1 0.0000